Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphisms of p53 codon 72 and MDM2 promoter 309 and the risk of endometrial cancer.

Human cell - 1 Nov 2009

Nunobiki Osamu, Ueda Masatsugu, Yamamoto Michiko, Toji Eisaku, Sato Naomi, Izuma Shinji, Okamoto Yoshiaki, Torii Kiyo, Noda Sadamu

Abstract excerpt

Genetic polymorphisms of p53 and its negative regulator murine double minute 2 homolog (MDM2) have been shown to be closely associated with tumorigenesis in a variety of human cancers. In the present study, single nucleotide polymorphism (SNP) at p53 codon 72 and MDM2 promoter 309 was examined for germline DNA samples from 102 endometrial cancer cases and 95 controls using polymerase chain reaction-based fragment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asian People
Share to Codon
Share to Endometrial Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, p53

Share to Polymorphism, Single Nucleotide

Share to Promoter Regions, Genetic

Share to Proto-Oncogene Proteins c-mdm2

Source

Identifiers

PMID: 19874399
DOI: 10.1111/j.1749-0774.2009.00075.x

Genes

MDM2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphisms of p53 codon 72 and MDM2 promoter 309 and the risk of endometrial cancer.PMID 19874399Read ↗

Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer.Semantic proximity Read ↗

MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis.Semantic proximity Read ↗

Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.Semantic proximity Read ↗

Murine double-minute 2 homolog single nucleotide polymorphism 309 and the risk of gynecologic cancer.Semantic proximity Read ↗

MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

Interaction of P53 Arg72Pro and MDM2 T309G polymorphisms and their associations with risk of gastric cardia cancer.Semantic proximity Read ↗

TP53 and MDM2 polymorphisms and the risk of endometrial cancer in postmenopausal women.Semantic proximity Read ↗

TP53 Arg 72Pro and MDM2 SNP309 polymorphisms and colorectal cancer risk: a west Algerian population study.Semantic proximity Read ↗

Risk of MDM2 SNP309 alone or in combination with the p53 codon 72 polymorphism in acute myeloid leukemia.Semantic proximity Read ↗

Effects of p53 codon 72 and MDM2 SNP309 polymorphisms on gastric cancer risk among the Iranian population.Semantic proximity Read ↗

Germline polymorphism of p53 codon 72 in gynecological cancer.Semantic proximity Read ↗

Common variant on MDM2 contributes to endometrial cancer susceptibility: evidence based on 7 studies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.